文献
J-GLOBAL ID:201702258907454287
整理番号:17A1719122
Toll様受容体8作動薬ナノ粒子は生BCGワクチンの免疫調節作用を模倣し,新生児先天性および適応免疫応答を増強する【Powered by NICT】
Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses
著者 (36件):
Dowling David J.
(Department of Medicine, Division of Infectious Diseases, Boston Children’s Hospital, Boston, Mass)
,
Dowling David J.
(Harvard Medical School, Boston, Mass)
,
Scott Evan A.
(Department of Biomedical Engineering, Northwestern University, Evanston, Ill)
,
Scheid Annette
(Department of Medicine, Division of Infectious Diseases, Boston Children’s Hospital, Boston, Mass)
,
Scheid Annette
(Harvard Medical School, Boston, Mass)
,
Scheid Annette
(Division of Newborn Medicine, Floating Hospital for Children, Tufts Medical Center, Boston, Mass)
,
Scheid Annette
(Precision Vaccine Program, Division of Infectious Diseases, Boston Children’s Hospital, Boston, Mass)
,
Bergelson Ilana
(Department of Medicine, Division of Infectious Diseases, Boston Children’s Hospital, Boston, Mass)
,
Joshi Sweta
(Department of Medicine, Division of Infectious Diseases, Boston Children’s Hospital, Boston, Mass)
,
Joshi Sweta
(Precision Vaccine Program, Division of Infectious Diseases, Boston Children’s Hospital, Boston, Mass)
,
Pietrasanta Carlo
(Department of Medicine, Division of Infectious Diseases, Boston Children’s Hospital, Boston, Mass)
,
Pietrasanta Carlo
(Harvard Medical School, Boston, Mass)
,
Pietrasanta Carlo
(Neonatal Intensive Care Unit, Department of Clinical Sciences and Community Health, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy)
,
Pietrasanta Carlo
(Precision Vaccine Program, Division of Infectious Diseases, Boston Children’s Hospital, Boston, Mass)
,
Brightman Spencer
(Department of Medicine, Division of Infectious Diseases, Boston Children’s Hospital, Boston, Mass)
,
Brightman Spencer
(Precision Vaccine Program, Division of Infectious Diseases, Boston Children’s Hospital, Boston, Mass)
,
Sanchez-Schmitz Guzman
(Department of Medicine, Division of Infectious Diseases, Boston Children’s Hospital, Boston, Mass)
,
Sanchez-Schmitz Guzman
(Harvard Medical School, Boston, Mass)
,
Sanchez-Schmitz Guzman
(Precision Vaccine Program, Division of Infectious Diseases, Boston Children’s Hospital, Boston, Mass)
,
Van Haren Simon D.
(Department of Medicine, Division of Infectious Diseases, Boston Children’s Hospital, Boston, Mass)
,
Van Haren Simon D.
(Harvard Medical School, Boston, Mass)
,
Van Haren Simon D.
(Precision Vaccine Program, Division of Infectious Diseases, Boston Children’s Hospital, Boston, Mass)
,
Ninkovic Jana
(Department of Medicine, Division of Infectious Diseases, Boston Children’s Hospital, Boston, Mass)
,
Ninkovic Jana
(Harvard Medical School, Boston, Mass)
,
Kats Dina
(Department of Biomedical Engineering, Northwestern University, Evanston, Ill)
,
Guiducci Cristiana
(Dynavax Technologies, Berkeley, Calif)
,
de Titta Alexandre
(Institute of Bioengineering, School of Life Sciences and School of Engineering, Ecole Polytechnique Federale de Lausanne (EPFL), Lausanne, Switzerland)
,
Bonner Daniel K.
(Institute of Bioengineering, School of Life Sciences and School of Engineering, Ecole Polytechnique Federale de Lausanne (EPFL), Lausanne, Switzerland)
,
Hirosue Sachiko
(Institute of Bioengineering, School of Life Sciences and School of Engineering, Ecole Polytechnique Federale de Lausanne (EPFL), Lausanne, Switzerland)
,
Swartz Melody A.
(Institute of Bioengineering, School of Life Sciences and School of Engineering, Ecole Polytechnique Federale de Lausanne (EPFL), Lausanne, Switzerland)
,
Swartz Melody A.
(Institute for Molecular Engineering, University of Chicago, Chicago, Ill)
,
Hubbell Jeffrey A.
(Institute of Bioengineering, School of Life Sciences and School of Engineering, Ecole Polytechnique Federale de Lausanne (EPFL), Lausanne, Switzerland)
,
Hubbell Jeffrey A.
(Institute for Molecular Engineering, University of Chicago, Chicago, Ill)
,
Levy Ofer
(Department of Medicine, Division of Infectious Diseases, Boston Children’s Hospital, Boston, Mass)
,
Levy Ofer
(Harvard Medical School, Boston, Mass)
,
Levy Ofer
(Precision Vaccine Program, Division of Infectious Diseases, Boston Children’s Hospital, Boston, Mass)
資料名:
Journal of Allergy and Clinical Immunology
(Journal of Allergy and Clinical Immunology)
巻:
140
号:
5
ページ:
1339-1350
発行年:
2017年
JST資料番号:
A0182B
ISSN:
0091-6749
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)